This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
Research grant to understand and treat long-term side effects of cancer therapy through mechanistic and clinical studies supporting therapeutic interventions.
Innovation in Regulatory Science supports academic investigators developing tools, standards, and approaches to strengthen regulatory decisions and protect human health and safety.
This cooperative agreement supports cancer registry workforce training, better surveillance data, and wider use of National Program of Cancer Registries data in research and public health decisions.